Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Jan 1;143(1):232–237. doi: 10.1084/jem.143.1.232

Differential effects of chlorpromazine on the in vitro generation and effector function of cytotoxic lymphocytes

RM Ferguson, Schmidtke JR, RL Simmons
PMCID: PMC2190091  PMID: 1244420

Abstract

Allograft rejection represents a cytotoxic response mediated to a large degree by thymus-derived T lymphocytes (1). The study of such cell-mediated cytotoxic phenomena has been greatly facilitated by the discovery first noted by Hayry and Defendi (2) and Wunderlich and Cany (3), that a natural consequence of allogeneic stimulation in an unidirectional mixed lymphocyte culture (MLC) was the appearance of cytotoxic lymphocytes specific for antigens present on the stimulator cells. Subsequent studies have shown that such in vitro generation of cytotoxic lymphocytes was dependent on the proliferative response in an MLC (4), was genetically determined (5), and possibly required the interaction of several subpopulations of T cells (6). We now report that the surface active agent chlorpromazine: (a) inhibits allogeneic stimulation of the proliferative response in an MLC; (b) inhibits the MLC generation of cytotoxic lymphocytes, (c) has no effect on the recognition, binding, or lysis of target cells by already sensitized lymphocytes; and (d) blocks a postproliferative membrane-mediated event, independent of proliferation, and necessary for the MLC generation of cytotoxic lymphocytes.

Full Text

The Full Text of this article is available as a PDF (412.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., Segall M., Zier K. S., Sondel P. M., Alter B. J., Bach M. L. Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science. 1973 Apr 27;180(4084):403–406. doi: 10.1126/science.180.4084.403. [DOI] [PubMed] [Google Scholar]
  2. Cantor H., Boyse E. A. Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med. 1975 Jun 1;141(6):1390–1399. doi: 10.1084/jem.141.6.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantor H., Boyse E. A. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med. 1975 Jun 1;141(6):1376–1389. doi: 10.1084/jem.141.6.1376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantor H., Jandinski J. The relationship of cell division to the generation of cytotoxic activity in mixed lymphocyte culture. J Exp Med. 1974 Dec 1;140(6):1712–1716. doi: 10.1084/jem.140.6.1712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cantor H., Simpson E., Sato V. L., Fathman C. G., Herzenberg L. A. Characterization of subpopulations of T lymphocytes. I. Separation and functional studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 (theta) antibody using a fluorescence-activated cell sorter (FACS). Cell Immunol. 1975 Jan;15(1):180–196. doi: 10.1016/0008-8749(75)90174-4. [DOI] [PubMed] [Google Scholar]
  6. Ferguson R. M., Schmidtke J. R., Simmons R. L. Concurrent inhibition by chlorpromazine of concanavalin A-induced lymphocyte aggregation and mitogenesis. Nature. 1975 Aug 28;256(5520):744–745. doi: 10.1038/256744a0. [DOI] [PubMed] [Google Scholar]
  7. Hodes R. J., Handwerger B. S., Terry W. D. Synergy between subpopulations of mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity: evidence for the involvement of a non-T cell. J Exp Med. 1974 Dec 1;140(6):1646–1659. doi: 10.1084/jem.140.6.1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Häyry P., Defendi V. Mixed lymphocyte cultures produce effector cells: model in vitro for allograft rejection. Science. 1970 Apr 3;168(3927):133–135. doi: 10.1126/science.168.3927.133. [DOI] [PubMed] [Google Scholar]
  9. Miller J. F., Brunner K. T., Sprent J., Russell P. J., Mitchell G. F. Thymus-derived cells as killer cells in cell-mediated immunity. Transplant Proc. 1971 Mar;3(1):915–917. [PubMed] [Google Scholar]
  10. Nabholz M., Vives J., Young H. M., Meo T., Miggiano V., Rijnbeek A., Shreffler D. C. Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse. Eur J Immunol. 1974 May;4(5):378–387. doi: 10.1002/eji.1830040514. [DOI] [PubMed] [Google Scholar]
  11. Schendel D. J., Alter B. J., Bach F. H. The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc. 1973 Dec;5(4):1651–1655. [PubMed] [Google Scholar]
  12. Schendel D. J., Bach F. H. Genetic control of cell-mediated lympholysis in mouse. J Exp Med. 1974 Dec 1;140(6):1534–1546. doi: 10.1084/jem.140.6.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev. 1972 Dec;24(4):583–655. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES